Citigroup’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $301K | Sell |
130,317
-2,877
| -2% | -$6.65K | ﹤0.01% | 3164 |
|
|
2025
Q1 | $185K | Sell |
133,194
-120,098
| -47% | -$167K | ﹤0.01% | 3485 |
|
|
2024
Q4 | $438K | Buy |
253,292
+120,680
| +91% | +$209K | ﹤0.01% | 3111 |
|
|
2024
Q3 | $267K | Buy |
132,612
+88,677
| +202% | +$178K | ﹤0.01% | 3392 |
|
|
2024
Q2 | $98.4K | Sell |
43,935
-211,268
| -83% | -$473K | ﹤0.01% | 3498 |
|
|
2024
Q1 | $732K | Sell |
255,203
-55,760
| -18% | -$160K | ﹤0.01% | 2592 |
|
|
2023
Q4 | $550K | Buy |
310,963
+29,844
| +11% | +$52.8K | ﹤0.01% | 2624 |
|
|
2023
Q3 | $888K | Buy |
+281,119
| New | +$888K | ﹤0.01% | 2001 |
|
|
2022
Q4 | – | Sell |
-635
| Closed | -$1K | – | 5047 |
|
|
2022
Q3 | $1K | Sell |
635
-523
| -45% | -$824 | ﹤0.01% | 4863 |
|
|
2022
Q2 | $4K | Sell |
1,158
-9,158
| -89% | -$31.6K | ﹤0.01% | 4937 |
|
|
2022
Q1 | $67K | Sell |
10,316
-291
| -3% | -$1.89K | ﹤0.01% | 3913 |
|
|
2021
Q4 | $124K | Buy |
10,607
+7,286
| +219% | +$85.2K | ﹤0.01% | 3863 |
|
|
2021
Q3 | $62K | Buy |
3,321
+1,950
| +142% | +$36.4K | ﹤0.01% | 3887 |
|
|
2021
Q2 | $29K | Buy |
1,371
+795
| +138% | +$16.8K | ﹤0.01% | 4431 |
|
|
2021
Q1 | $12K | Sell |
576
-1,038
| -64% | -$21.6K | ﹤0.01% | 4893 |
|
|
2020
Q4 | $43K | Buy |
+1,614
| New | +$43K | ﹤0.01% | 4197 |
|